Comment www. thelancet. com Vol 374 July 25, 2009 273 and the inability of the MHRA to
prosecute weakens NICE's ability to make evidence-based judgments and to provide robust …

Responding to a dearth of new drug approvals in recent years, US National Institutes of
Health (NIH) director Francis Collins is working to establish a centre to bolster the …

Sir—In your June 24 editorial1 you note that industry is increasingly using questionable
methods to persuade investigators and patients to help it pursue commercial agendas. Such …

Special Report www. thelancet. com Vol 372 July 19, 2008 193 the source, who asked not to
be named.“But we are optimistic and hope the Italians complete our unfinished business …

Elsevier, The Lancet's publisher, con tinues to subsidise climate pollution through analytic
tools and new jour nals supporting coal, oil, and gas explo ration and extraction—an …

Reports on the United States Food and Drug Administration (FDA) Commissioner David
Kessler's testimony before a congressional committee that proposed FDA approval reforms …

The trust that authors place in editors, and editors in reviewers, creates a precious
opportunity to strengthen manuscripts and advance science. The Lancet values deeply the …

Thornton noted that people living on the margins of prescription areas were moving, if they
needed to. For example, many HIV patients moved to north London when they heard better …

Registering clinical trials: an essential role for WHO - The Lancet Skip to Main Content
Advertisement The Lancet Journal Submit Article Log in Register Log in Submit Article Log in …

Double dealing with your data. КОРЗИНА ПОИСК НАВИГАТОР ЖУРНАЛЫ КНИГИ ПАТЕНТЫ
ПОИСК АВТОРЫ ОРГАНИЗАЦИИ КЛЮЧЕВЫЕ СЛОВА РУБРИКАТОР Начальная страница …